Risperidone Tablets bulk supplier for pharma manufacturers

Risperidone Tablets Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg

Reference Brands: Risperdal®(US & EU); EU: Risperidon-ratiopharm®, Rispolept®, Rispen® '

Risperidone acts by antagonizing dopamine D2 and serotonin 5-HT2A receptors, balancing neurotransmitter activity in the brain. It is used to treat schizophrenia, acute manic or mixed episodes of bipolar disorder, and irritability in autistic children. It helps reduce hallucinations, mood swings, and aggression, improving daily functioning.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Risperidone tablets are approved in both the USA and EU for the treatment of schizophrenia, bipolar I disorder, and irritability associated with autistic disorder. In the US, the FDA regulates risperidone under NDA pathways, ensuring rigorous quality and efficacy standards. In the EU, risperidone is authorized through national procedures and mutual recognition among member states. Available in multiple strengths, these tablets offer tailored dosing options. Risperidone's classification as an atypical antipsychotic supports its broad clinical application. To explore more forms and global availability of Risperidone, visit Pharmatradz.com.

Risperidone Tablets — third party manufacturing & bulk supply

Risperidone Tablets is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Risperidone Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Risperidone Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Risperidone Tablets →

Back to Listing

Frequently Asked Questions

Risperidone tablets are used to treat schizophrenia, bipolar mania, and irritability associated with autistic disorder. The medicine helps reduce symptoms such as hallucinations, aggression, mood swings, and disturbed thinking by balancing dopamine and serotonin activity in the brain.

Risperidone tablets are made from the active pharmaceutical ingredient risperidone, which is an atypical antipsychotic compound formulated into tablet dosage forms along with standard pharmaceutical excipients to allow proper absorption and effectiveness.

The most widely known trade name is Risperdal tablets, along with other regional brands such as Sizodon tablets and Risdone tablets depending on the manufacturer and market.

Risperdal tablets were originally developed and marketed by Janssen Pharmaceuticals. Generic risperidone tablets are manufactured by many pharmaceutical companies globally, including Sun Pharmaceutical Industries and Teva Pharmaceuticals, among others.

The generic name is risperidone.

Common brand names include Risperdal tablets, Sizodon tablets, Risdone tablets, and other local brands available in different countries.

Risperidone tablets are manufactured in several countries including the United States, India, and multiple European countries in pharmaceutical facilities approved by regulatory authorities such as the US FDA, EMA, and other national drug regulatory agencies.